Markus Eckstein News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Under the leadership of PD Dr. Niklas Klümper, Assistant Physician at the Department of Urology at the University Hospital Bonn (UKB) and Clinician Scientist of the BMBF-funded ACCENT program and PD Dr. Markus Eckstein, senior physician at the Institute of Pathology at the Uniklinikum Erlangen of the Friedrich-Alexander-University Erlangen-Nürnberg (FAU), an interdisciplinary research team has published new findings that indicate which patients with advanced urothelial carcinoma could benefit in particular from the new targeted therapy with the antibody-drug conjugate enfortumab vedotin.

– Cutting-edge spatial omics technologies to map cancer cells and their immune environment in high resolution, allowing AI to unlock potential for new breakthrough treatments –– Landmark research project is 100x larger than existing efforts –– Data will be generated from thousands of patients across multiple cancers...

– Cutting-edge spatial omics technologies to map cancer cells and their immune environment in high resolution, allowing AI to unlock potential for new breakthrough treatments – –... | June 1, 2023

Cutting-edge spatial omics technologies to map cancer cells and their immune environment in high resolution, allowing AI to unlock potential for new breakthrough treatments Landmark research project

MOSAIC aims to be the world's largest spatial omics project in cancer research. Owkin is the sponsor of this $50 million research initiative that combines its AI expertise with technological know-how from NanoString and the clinical expertise of 5 world class cancer research centers across Europe and the USA.